FDA confirms Sinopharm applied for vaccine emergency use in PH

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

(FILE PHOTO)

Metro Manila (CNN Philippines, March 2)— The Food And Drug Administration on Tuesday confirmed receipt of an application from China's state-owned pharmaceutical giant Sinopharm with regards to its vaccine’s emergency use in the country.

FDA Director General Eric Domingo told CNN Philippines that a representative of the vaccine manufacturer filed an online application for EUA, but noted that the attached documents are still being reviewed.

“I did have my staff check it now… And then online, yesterday afternoon, an applicant did send an application for EUA for Sinopharm. So meron ngang dumating daw kahapon (an application really was filed yesterday),” Domingo said in an interview with The Source.

“So they’re looking at the documents now to see kung (if) complete or if there are any documents that need to be submitted before we officially accept the application,” he added.

It was Presidential Spokesperson Harry Roque who revealed on Monday that the manufacturer sent an application for EUA in the Philippines. The FDA chief earlier said the evaluation on Sinopharm’s vaccine may take a longer period of time, since it has not received an EUA from any stringent regulatory body.

The country's FDA has so far granted emergency use authorization to the vaccines of Pfizer-BioNTech, AstraZeneca, and China-based manufacturer Sinovac Biotech.

Meanwhile, the EUA application of Russia’s Gamaleya Research Institute also remains pending, with the regulatory body still waiting for additional documents for the Sputnik V vaccine, Domingo said.

RELATED: Moderna, Novavax next potential applicants for emergency use in PH — FDA